IRLAB Therapeutics AB (publ) (IRLAB-A.ST)
SEK 11.25
(0.0%)
SEK 11.25
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.67 Million | 61.13 Million | 207.78 Million | 300 Thousand | 26 Thousand | 18 Thousand |
| Cost of Revenue | 128.41 Million | 172.36 Million | 39.09 Million | 1.99 Million | 96.22 Million | 74.09 Million |
| Gross Profit | -122.73 Million | -111.23 Million | 168.69 Million | -1.69 Million | -96.2 Million | -74.07 Million |
| Operating Expenses | 58.03 Million | 174.24 Million | 116.11 Million | 91.45 Million | 95.94 Million | 73.91 Million |
| Selling, General and Administrative Expenses | -151.31 Million | 125.9 Million | 81.73 Million | 65.63 Million | 71.16 Million | 54.27 Million |
| Research and Development Expenses | 151.31 Million | 146.17 Million | 39.35 Million | 76.24 Million | 79.38 Million | 58.92 Million |
| Other Expenses | - | 48.33 Million | 34.37 Million | 25.82 Million | 24.78 Million | 19.64 Million |
| Cost and Expenses | 186.44 Million | 174.24 Million | 155.2 Million | 91.45 Million | 95.94 Million | 73.91 Million |
| Operating Income | -180.76 Million | -113.1 Million | 52.57 Million | -91.45 Million | -95.84 Million | -73.89 Million |
| Interest Expense | 198 Thousand | 297 Thousand | 370 Thousand | 195 Thousand | 272 Thousand | 202 Thousand |
| Income Tax Expense | - | 797 Thousand | 370 Thousand | 195 Thousand | 198 Thousand | 202 Thousand |
| Earnings before Tax | -177.83 Million | -113.4 Million | 51.78 Million | -91.65 Million | -96.12 Million | -74.09 Million |
| Net Income | -177.83 Million | -114.2 Million | 51.78 Million | -91.84 Million | -96.31 Million | -74.09 Million |
| Earnings Per Share Basic | -3.43 | -2.20 | 1.00 | -1.93 | -2.33 | -1.90 |
| Earnings Per Share Diluted | -3.43 | -2.20 | 1.00 | -1.93 | -2.33 | -1.90 |
| Weighted Average Shares Outstanding | 51.86 Million | 51.83 Million | 51.74 Million | 47.67 Million | 41.3 Million | 38.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.86 Million | 51.83 Million | 51.74 Million | 47.67 Million | 41.3 Million | 38.91 Million |
| Gross Margin | -21.62 | -1.82 | 0.81 | -5.66 | -3700.12 | -4115.28 |
| EBIT Margin | -30.53 | -1.77 | 0.27 | -297.34 | -3576.54 | -4031.39 |
| Profit Margin | -31.32 | -1.87 | 0.25 | -306.16 | -3704.54 | -4116.61 |
| EBITDA | -173.32 Million | -109.12 Million | 55.36 Million | -89.46 Million | -93.17 Million | -72.56 Million |
| Earnings Before Tax Margin | -31.84 | -1.85 | 0.25 | -304.86 | -3686.46 | -4105.39 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 9.03 Million | 42.77 Million | - | -1.19 Million | 5.67 Million | - |
| Cost of Revenue | 45.74 Million | 52.29 Million | 1.15 Million | 34.38 Million | 185.81 Million | 1.08 Million |
| Gross Profit | -36.71 Million | -9.52 Million | -1.15 Million | -35.57 Million | -180.13 Million | -1.08 Million |
| Operating Expenses | - | 47.87 Million | 36.2 Million | 34.45 Million | 186.44 Million | 40.73 Million |
| Selling, General and Administrative Expenses | -38.28 Million | -49.07 Million | 7.27 Million | 10.86 Million | - | 5.04 Million |
| Research and Development Expenses | 38.28 Million | 49.07 Million | 28.93 Million | 29.65 Million | - | 34.97 Million |
| Other Expenses | - | -52.34 Million | - | - | - | - |
| Cost and Expenses | 45.74 Million | 52.29 Million | 37.36 Million | 34.38 Million | 185.81 Million | 40.73 Million |
| Operating Income | -36.71 Million | -9.52 Million | -37.36 Million | -35.57 Million | -180.13 Million | -40.73 Million |
| Interest Expense | 2.93 Million | 2.47 Million | 2.09 Million | 82 Thousand | 198 Thousand | 27 Thousand |
| Income Tax Expense | 7.99 Million | 1.00 | 1.1 Million | 1.02 Million | 4.14 Million | 2.37 Million |
| Earnings before Tax | -31.65 Million | -7.05 Million | -39.01 Million | -34.98 Million | -177.83 Million | -38.39 Million |
| Net Income | -31.65 Million | -7.05 Million | -39.01 Million | -34.98 Million | -177.83 Million | -38.39 Million |
| Earnings Per Share Basic | -0.61 | -0.14 | -0.75 | -0.67 | - | -0.74 |
| Earnings Per Share Diluted | -0.61 | -0.14 | -0.75 | -0.67 | - | -0.74 |
| Weighted Average Shares Outstanding | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million | 51.86 Million |
| Gross Margin | -4.06 | -0.22 | - | 29.85 | -31.72 | - |
| EBIT Margin | -3.05 | -0.20 | - | 28.95 | - | - |
| Profit Margin | -3.51 | -0.16 | - | 29.35 | -31.32 | - |
| EBITDA | -27.56 Million | -8.36 Million | -36.2 Million | -34.5 Million | - | -37.28 Million |
| Earnings Before Tax Margin | -4.06 | -0.22 | - | 29.85 | -31.72 | - |
CDNAF
9852
LAHAV
CRI
TSPOR
AHL-PD